KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Other Accumulated Expenses (2016 - 2018)

NovoCure's Other Accumulated Expenses history spans 5 years, with the latest figure at $32000.0 for Q4 2018.

  • For Q4 2018, Other Accumulated Expenses fell 77.78% year-over-year to $32000.0; the TTM value through Dec 2018 reached $32000.0, down 77.78%, while the annual FY2018 figure was $32000.0, 77.78% down from the prior year.
  • Other Accumulated Expenses for Q4 2018 was $32000.0 at NovoCure, down from $144000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $712000.0 in Q4 2015 and bottomed at $32000.0 in Q4 2018.
  • The 5-year median for Other Accumulated Expenses is $97000.0 (2014), against an average of $212200.0.
  • The largest annual shift saw Other Accumulated Expenses surged 634.02% in 2015 before it crashed 89.33% in 2016.
  • A 5-year view of Other Accumulated Expenses shows it stood at $97000.0 in 2014, then soared by 634.02% to $712000.0 in 2015, then plummeted by 89.33% to $76000.0 in 2016, then surged by 89.47% to $144000.0 in 2017, then crashed by 77.78% to $32000.0 in 2018.
  • Per Business Quant, the three most recent readings for NVCR's Other Accumulated Expenses are $32000.0 (Q4 2018), $144000.0 (Q4 2017), and $76000.0 (Q4 2016).